Patents by Inventor Frederick H. Strickler, Jr.

Frederick H. Strickler, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REACTIVE POLYSACCHARIDE-BASED HEMOSTATIC AGENT
    Publication number: 20240002549
    Abstract: Compositions and methods related to powdered hemostats that crosslink during and/or after application to a bleeding site are generally described.
    Type: Application
    Filed: June 30, 2023
    Publication date: January 4, 2024
    Applicant: Davol Inc.
    Inventors: Keith Greenawalt, Christopher Bowley, Jessica Powell, Rajendra R. Bhat, Michael T. Cash, Aaron D. Strickland, Esther M. Valliant, Frederick H. Strickler, JR., Andrew C. Yang
  • Reactive polysaccharide-based hemostatic agent
    Patent number: 11739166
    Abstract: Compositions and methods related to powdered hemostats that crosslink during and/or after application to a bleeding site are generally described.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: August 29, 2023
    Assignee: Davol Inc.
    Inventors: Keith Greenawalt, Christopher Bowley, Jessica Powell, Rajendra R. Bhat, Michael T. Cash, Aaron D. Strickland, Esther M. Valliant, Frederick H. Strickler, Jr., Andrew C. Yang
  • REACTIVE DRY POWDERED HEMOSTATIC MATERIALS COMPRISING A NUCLEOPHILE AND A MULTIFUNCTIONAL MODIFIED POLYETHYLENE GLYCOL BASED CROSSLINKING AGENT
    Publication number: 20220323637
    Abstract: Compositions and methods related to powdered hemostats that crosslink during and/or after application to a bleeding site are described. The compositions may comprise a first component comprising a polyalkylene oxide-based polymer functionalized with electrophilic reactive groups, and a second component that comprises a protein such as albumin and an optional crosslinking initiator—which may be a base or basic salt such as sodium bicarbonate. The compositions may in certain applications act as hemostats when applied in dry powder form to a bleeding wound, whereupon the first component and the second component of the composition crosslink to form a hydrogel.
    Type: Application
    Filed: June 25, 2020
    Publication date: October 13, 2022
    Applicant: Davol Inc.
    Inventors: Keith Greenawalt, Frederick H. Strickler, JR.
  • REACTIVE DRY POWDERED HEMOSTATIC MATERIALS COMPRISING A PROTEIN AND A MULTIFUNCTIONALIZED MODIFIED POLYETHYLENE GLYCOL BASED CROSSLINKING AGENT
    Publication number: 20220211900
    Abstract: Compositions and methods related to powdered hemostats that crosslink during and/or after application to a bleeding site are described. The compositions may comprise a first component comprising a multifunctionalized polymeric composition (e.g., multifunctionalized polyethylene glycol) functionalized with electrophilic reactive groups, and a second component that comprises a protein such as albumin. The compositions may in certain applications act as hemostats when applied in dry powder form to a bleeding wound, whereupon the first component and the second component of the composition crosslink to form a hydrogel.
    Type: Application
    Filed: December 27, 2021
    Publication date: July 7, 2022
    Applicant: Davol Inc.
    Inventors: Keith Greenawalt, Frederick H. Strickler, JR.
  • FLOWABLE HEMOSTATIC SUSPENSION
    Publication number: 20220001075
    Abstract: Compositions and methods related to flowable hemostats that crosslink during and/or after application to a bleeding site are generally described.
    Type: Application
    Filed: July 1, 2021
    Publication date: January 6, 2022
    Applicant: Davol Inc.
    Inventors: Keith Greenawalt, Christopher Bowley, Frederick H. Strickler, JR., Andrew C. Yang, Rajendra R. Bhat, Jessica Powell, Michael T. Cash, Aaron D. Strickland, Esther M. Valliant
  • REACTIVE POLYSACCHARIDE-BASED HEMOSTATIC AGENT
    Publication number: 20220002444
    Abstract: Compositions and methods related to powdered hemostats that crosslink during and/or after application to a bleeding site are generally described.
    Type: Application
    Filed: July 1, 2021
    Publication date: January 6, 2022
    Applicant: Davol Inc.
    Inventors: Keith Greenawalt, Christopher Bowley, Jessica Powell, Rajendra R. Bhat, Michael T. Cash, Aaron D. Strickland, Esther M. Valliant, Frederick H. Strickler, JR., Andrew C. Yang
  • Implant
    Patent number: D841809
    Type: Grant
    Filed: July 2, 2015
    Date of Patent: February 26, 2019
    Assignee: C.R. Bard, Inc.
    Inventors: Christopher W. Gelinas, Stephen N. Eldridge, Jon I. Montcrieff, Sarah B. Borysenko, Frederick H. Strickler, Jr., Scott Narkevicius
  • Implant
    Patent number: D894392
    Type: Grant
    Filed: January 23, 2019
    Date of Patent: August 25, 2020
    Assignee: C.R. Bard, Inc.
    Inventors: Christopher W. Gelinas, Stephen N. Eldridge, Jon I. Montcrieff, Sarah B. Borysenko, Frederick H. Strickler, Jr., Scott Narkevicius
  • Implant
    Patent number: D993415
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: July 25, 2023
    Assignee: C.R. Bard, Inc.
    Inventors: Christopher W. Gelinas, Stephen N. Eldridge, Jon I. Montcrieff, Sarah B. Borysenko, Frederick H. Strickler, Jr., Scott Narkevicius